Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Schwemmers, S"'
Autor:
Murugesan, K., Necchi, A., Burn, T.C., Gjoerup, O., Greenstein, R., Krook, M., López, J.A., Montesion, M., Nimeiri, H., Parikh, A.R., Roychowdhury, S., Schwemmers, S., Silverman, I.M., Vogel, A.
Publikováno v:
In ESMO Open December 2022 7(6)
Autor:
Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, Republic of Korea. Electronic address: CBC1971@yuhs.ac., Chiu CH; Taipei Cancer Center and Taipei Medical University Hospital, Taipei Medical University, No. 252, Wuxing St, Xinyi District, Taipei City, Taipei 110, Taiwan. Electronic address: chaohuachiu@tmu.edu.tw., Massarelli E; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 E Duarte Rd, Duarte, CA 91702, USA. Electronic address: emassarelli@coh.org., Buchschacher GL; Department of Hematology/Oncology, Kaiser Permanente Southern California, Los Angeles Medical Center, 4950 W Sunset Blvd, Los Angeles, CA 90027 USA. Electronic address: Gary.L.Buchschacher@kp.org., Goto K; National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. Electronic address: kgoto@east.ncc.go.jp., Overbeck TR; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany. Electronic address: tobias.overbeck@med.uni-goettingen.de., Loong HHF; Department of Clinical Oncology, The Chinese University of Hong Kong, Central Ave, Hong Kong, Hong Kong Special Administrative Region. Electronic address: h_loong@clo.cuhk.edu.hk., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore. Electronic address: cheng_ean_chee@nuhs.edu.sg., Garrido P; Medical Oncology Department, Ramón y Cajal University Hospital, M-607, 9, 100, 28034 Madrid, Spain. Electronic address: pilargarridol@gmail.com., Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: xhzzdxr@126.com., Fan Y; Department of Medical Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, China. Electronic address: fanyun@zjcc.org.cn., Lu S; Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. Electronic address: shunlu@sjtu.edu.cn., Schwemmers S; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: sven.schwemmers@roche.com., Bordogna W; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: walter.bordogna@roche.com., Zeuner H; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: harald.zeuner@roche.com., Osborne S; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland. Electronic address: stuart.osborne@roche.com., John T; Department of Medical Oncology, Peter McCallum Cancer Center, 305 Grattan St, Melbourne, VIC 3000, Australia. Electronic address: tom.john@petermac.org.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Feb; Vol. 188, pp. 107442. Date of Electronic Publication: 2023 Dec 15.
Autor:
Necchi, A., Murugesan, K., Burn, T., Gjoerup, O., Greenstein, R., López, J.A., Montesion, M., Nimeiri, H., Parikh, A.R., Roychowdhury, S., Schwemmers, S., Silverman, I.M., Vogel, A.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S584-S585
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jovanovic, J.V., Ivey, A., Vannucchi, A.M., Lippert, E., Leibundgut, E. Oppliger, Cassinat, B., Pallisgaard, N., Maroc, N., Hermouet, S., Nickless, G., Guglielmelli, P., Reijden, B.A. van der, Jansen, J.H., Alpermann, T., Schnittger, S., Bench, A., Tobal, K., Wilkins, B., Cuthill, K., McLornan, D., Yeoman, K., Akiki, S., Bryon, J., Jeffries, S., Jones, A., Percy, M.J., Schwemmers, S., Gruender, A., Kelley, T.W., Reading, S., Pancrazzi, A., McMullin, M.F., Pahl, H.L., Cross, N.C., Harrison, C.N., Prchal, J.T., Chomienne, C., Kiladjian, J.J., Barbui, T., Grimwade, D.
Publikováno v:
Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9
Item does not contain fulltext Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8db0b9a0e0a05667e1f59be8f8b90e3d
https://doi.org/10.1038/leu.2013.219
https://doi.org/10.1038/leu.2013.219
Autor:
Siegwart LC; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schwemmers S; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wehrle J; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Koellerer C; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Seeger T; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Gründer A; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Pahl HL; Division of Molecular Hematology, Department of Internal Medicine, Hematology/Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: Heike.Pahl@uniklinik-freiburg.de.
Publikováno v:
Experimental hematology [Exp Hematol] 2020 Jul; Vol. 87, pp. 42-47.e1. Date of Electronic Publication: 2020 Jun 25.
Autor:
Martín Castillo I; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., Villamón E; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., Calabuig M; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., Pastor I; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., Ferrer-Lores B; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain., Amat P; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain., Mas E; Hematology Department, Hospital Universitario de La Plana de Vila-Real, Villarreal, Spain., Castillo I; Hematology Department, Hospital Universitario de La Plana de Vila-Real, Villarreal, Spain., Blanco S; Hematology Department, Hospital Comarcal Francesc De Borja de Gandía, Valencia, Spain., Solano C; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain., Hernández-Boluda JC; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain., Tormo M; Hematology Department, Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Department of Medicine, University of Valencia, Valencia, Spain.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 733-737. Date of Electronic Publication: 2024 Jun 06.
Autor:
Zehnle, Patricia M. A.1,2 (AUTHOR), Wu, Ying1 (AUTHOR), Koleci, Naile1 (AUTHOR), Bohler, Sheila1 (AUTHOR), Erlacher, Miriam1 (AUTHOR) miriam.erlacher@uniklinik-freiburg.de
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p4105. 12p.
Autor:
Auerbach, Scott1 (AUTHOR) scott.auerbach@bilkent.edu.tr, Puka, Beana1 (AUTHOR) beana.puka@bilkent.edu.tr, Golla, Upendarrao2 (AUTHOR) ugolla@pennstatehealth.psu.edu, Chachoua, Ilyas1 (AUTHOR) ilyas.chachoua@bilkent.edu.tr
Publikováno v:
Life (2075-1729). Mar2024, Vol. 14 Issue 3, p309. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.